Low‐dose dexamethasone prevents endotoxaemia‐induced muscle protein loss and impairment of carbohydrate oxidation in rat skeletal muscle
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
We recently provided evidence suggesting a role for cytokine‐mediated inhibition of Akt/Forkhead box O 1 (FOXO1) signalling in the induction of muscle atrophy and impairment of muscle carbohydrate oxidation during lipopolysaccharide (LPS)‐induced endotoxaemia in rats. We hypothesized that a low‐dose dexamethasone (Dex; anti‐inflammatory agent) infusion during endotoxaemia would prevent the LPS‐induced impairment of Akt/FOXO1 signalling, and therefore prevent the muscle atrophy and impairment of carbohydrate oxidation. Chronically instrumented Sprague–Dawley rats received a continuous intravenous infusion of LPS (15 μg kg−1 h−1), Dex (12.5 μg kg−1 h−1), Dex+LPS or saline for 24 h at 0.4 ml h−1. LPS infusion caused haemodynamic changes consistent with a hyperdynamic circulation and induced increases in muscle tumour necrosis factor‐α (TNF‐α; 10‐fold, P < 0.001), interleukin‐6 (IL‐6; 14‐fold, P < 0.001) and metallothionein‐1A (MT‐1A; 187‐fold, P < 0.001) mRNA expression. Dex co‐administration abolished most of the haemodynamic effects of LPS and reduced the increase in muscle TNF‐α, IL‐6 and MT‐1A by 51% (P < 0.01), 85% (P < 0.001) and 58% (P < 0.01), respectively. Dex infusion during endotoxaemia also prevented the LPS‐induced 40% reduction in the muscle protein:DNA ratio and decrease in Akt phosphorylation, and partially prevented the reduction in FOXO1 phosphorylation. However, Dex did not prevent the LPS‐mediated increase in muscle atrophy F‐box (MAFbx) and muscle RING finger 1 (MuRF1) mRNA expression, but did significantly reduce the LPS‐mediated increase in cathepsin‐L mRNA expression and enzyme activity by 43% (P < 0.001) and 53% (P < 0.05), respectively. Furthermore, Dex suppressed LPS‐induced pyruvate dehydrogenase kinase 4 (PDK4) mRNA upregulation by ∼50% (P < 0.01), and prevented LPS‐mediated muscle glycogen breakdown and lactate accumulation. Thus, low‐dose Dex infusion during endotoxaemia prevented muscle atrophy and the impairment of carbohydrate oxidation, potentially through suppression of cytokine‐mediated Akt/FOXO inhibition, and blunting of cathepsin‐L‐mediated lysosomal protein breakdown.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00211-4 · Cited by 1,964
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression
Lecker, S. H., Jagoe, R. T., Gilbert, A., Gomes, M., Baracos, V., Bailey, J., Price, S. R., Mitch, W. E., & Goldberg, A. L. (2004) · The FASEB Journal · doi:10.1096/fj.03-0610com · Cited by 1,539 · cited 1×
“We also measured metallothionein-1A (MT-1A), a gene associated with oxidative stress that is markedly upregulated in atrophying muscle (Lecker et al. 2004; Mallinson et al. 2009).”
BackgroundIKKβ/NF-κB Activation Causes Severe Muscle Wasting in Mice
Cai, D., Frantz, J. D., Tawa, N. E., Melendez, P. A., Oh, B.-C., Lidov, H. G. W., Hasselgren, P.-O., Frontera, W. R., Lee, J., Glass, D. J., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.027 · Cited by 1,367
IL-6-induced skeletal muscle atrophy
Haddad, F., Zaldivar, F., Cooper, D. M., & Adams, G. R. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01026.2004 · Cited by 612
Wang, X., Hu, Z., Hu, J., Du, J., & Mitch, W. E. (2006) · Endocrinology · doi:10.1210/en.2006-0251 · Cited by 600
Muscle composition in relation to age and sex
Forsberg, A. M., Nilsson, E., Werneman, J., Bergström, J., & Hultman, E. (1991) · Clinical Science · doi:10.1042/cs0810249 · Cited by 282 · cited 1×
“Muscle alkaline-soluble protein and DNA was quantified according to Forsberg et al. (1991).”
MethodInsulin action and signalling in fat and muscle from dexamethasone-treated rats
Burén, J., Lai, Y. C., Lundgren, M., Eriksson, J. W., & Jensen, J. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.02.034 · Cited by 125 · cited 1×
“2008b), as well as muscle insulin resistance (Qi et al. 2004; Buren et al. 2008), we used a much lower dose (equivalent to 300 μg kg−1 day−1), in an attempt to suppress pro-inflammatory cytokine levels without producing the catabolic and insulin resistance effects that are associated with higher doses of glucocorticoi…”
Effect of hypercorticism on regulation of skeletal muscle glycogen metabolism by insulin
Coderre, L., Srivastava, A. K., & Chiasson, J. L. (1992) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1992.262.4.e427 · Cited by 17 · cited 1×
“There is no immediate explanation for this finding, although high doses of Dex have been previously shown to induce muscle glycogen synthesis (Coderre et al. 1992; Puthanveetil et al. 2008).”
Background
Cited by
Glucocorticoid-Induced Skeletal Muscle Atrophy
Schakman, O., Kalista, S., Barbé, C., Loumaye, A., & Thissen, J. P. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.05.036 · Cited by 705
Frailty and sarcopenia: The potential role of an aged immune system
Wilson, D., Jackson, T., Sapey, E., & Lord, J. M. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.01.006 · Cited by 573
Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients
Liu, T., Luo, S., Libby, P., & Shi, G.-P. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107587 · Cited by 273
The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D)
Raison, C. L., & Miller, A. H. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.2 · Cited by 253
Metadata
- Authors
- Crossland, H., Constantin‐Teodosiu, D., Greenhaff, P. L., & Gardiner, S. M.
- Venue
- The Journal of Physiology
- Publisher
- Wiley
- Published
- 2010-04-14
- Volume
- 588
- Issue
- 8
- Pages
- 1333-1347
- ISSN
- 0022-3751 (ISSN-L)
- 1469-7793
- OpenAlex
- W2118958754
- Cited by
- 55
- References
- 9
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Low‐dose dexamethasone prevents endotoxaemia‐induced muscle protein loss and impairment of carbohydrate oxidation in rat skeletal muscle. https://app.cochat.ai/papers/10.1113/jphysiol.2009.183699
- The paper
- Crossland, H., Constantin‐Teodosiu, D., Greenhaff, P. L., & Gardiner, S. M. (2010). Low‐dose dexamethasone prevents endotoxaemia‐induced muscle protein loss and impairment of carbohydrate oxidation in rat skeletal muscle. The Journal of Physiology. https://doi.org/10.1113/jphysiol.2009.183699
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.